NVT-21310-29772
2 vaccinations
4 coded responses
25 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 298 / SC
- Registered
- 2021-03-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-12
Registered in v-safe
-
2021-03-12
Dose 1 — Pfizer-BioNTech
- 2021-03-12
-
2021-03-13
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Diarrhea, Abdominal painAdult check-in
-
2021-03-14
Survey response — days 1–6 daily, dose 1MedDRA: Hyperhidrosis — Feeling: Good · Site: Pain · Fever · Diarrhea, Abdominal pain · Be unable to workFree text: Sweating.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-15
- 2021-03-16
-
2021-03-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Muscle or body achesAdult check-in
- 2021-03-18
- 2021-03-19
- 2021-03-26
-
2021-04-02
Dose 2 — Pfizer-BioNTech
- 2021-04-02
-
2021-04-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-04-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-06
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-08
- 2021-04-09
-
2021-04-16
Survey response — day 14, dose 2MedDRA: Migraine — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: MigraineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-07-04
-
2021-10-03
Survey response — 6 months, dose 2MedDRA: Headache, Oropharyngeal pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Sore throat HeadacheMedDRA releases: 2024-11 · check-in free text available
-
2022-04-02
Survey response — 12 months, dose 2MedDRA: Intervertebral disc protrusion, Rash, Sciatica, Swelling face — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Bulging disc, sciatica, face swelling & rashMedDRA releases: 2024-11 · check-in free text available
-
2022-04-02
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-06
- 2022-04-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Pfizer-BioNTech | |
| 2 | 2021-04-02 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Sweating.
Release 7 — day 14, dose 2
Symptoms: Migraine
Release 9 — 6 months, dose 2
Symptoms: Sore throat Headache
Release 11 — 12 months, dose 2
Symptoms: Bulging disc, sciatica, face swelling & rash
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Intervertebral disc protrusion | · | · | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Sciatica | · | · | ✓ |
| SD | Swelling face | · | · | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release